PAA 2.27% 22.5¢ pharmaust limited

Ann: Appendix 4C and Quarterly Update, page-29

  1. 11,846 Posts.
    lightbulb Created with Sketch. 6002

    Imagine if PAA had a Valuation of the IP? it was stated in a previous valuation the IP was close to $100m

    PAA the Commercial Entity requires a Commercial Valuation , Investors always like to clarify something is undervalued and a formal valuation would demonstrate "True Underlying Value"

    What is a Covid Treatment worth ? easy to swallow Tablets that treat Covid in days not weeks, reduces long Covid Damage and doesnt require a Clinician?
    Can be dropped into remote areas and does not require refrigeration?

    K9 Cancer Treatment that delivers Quality of Life and some life extension?? whats the True Value?

    Human Cancer , well the ONJF confirmed MPL had a Positive Effect on 28 out of 30 Human Cancers including Ovarian and Breast Cancers..?

    MND Treatment , Delivering Quality of Life and Certainly Life Extension $

    I put too every share holder its a long way North of $24m and 7c a share,, IMHO Valuation required now before the next CR to protect SH Value...PAA's History is for a 20% discount on previous CR's... now they need to raise at a Premium , the Company keep devaluing their own success and confirmation to date.

    Remember that $6.4m was raised with JP Equities @12c for the Human Cancer Trial ,,, would have been highly beneficial to have MT with a decent purse to work with..

    Company Messaging has lifted significantly and the Quality of presentations is now on par with other ASX Investment Options. currently 206 Biotechs and Baby Pharma on the ASX so PAA need to recognise they are competing for INVESTOR FUNDS and SH require a Return..

    Capitalising on Scientific Progress has been ignored previously " Oh it's all about the Science" well NO its not "That's what Research Institutes are for"
    Sure the Value is in the Science but that needs to be converted methodically into SH value , as risk is reduced with the confirmation of success from Scientific Trialing the Treatment MPL steps closer towards commercialisation..

    What's required is a concerted effort to inform the market of the Value and the Value of all of the Positive Data gathered to date...NZT

    Regrettably the Charts don't lie..... 7c? and from where I'm sitting this Christmas will continue to see retail investors leaving the ASX
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
22.5¢
Change
0.005(2.27%)
Mkt cap ! $100.1M
Open High Low Value Volume
22.0¢ 22.5¢ 21.5¢ $194.1K 889.8K

Buyers (Bids)

No. Vol. Price($)
2 4996 22.0¢
 

Sellers (Offers)

Price($) Vol. No.
22.5¢ 114999 4
View Market Depth
Last trade - 16.10pm 16/07/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.